These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 13367337)

  • 1. Studies on the nature and the purification of the coagulase-reacting factor and its relation to prothrombin.
    TAGER M
    J Exp Med; 1956 Nov; 104(5):675-86. PubMed ID: 13367337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of the physiological blood clotting process on the coagulation of blood by staphylocoagulase.
    TAGER M; LODGE AL
    J Exp Med; 1951 Jul; 94(1):73-85. PubMed ID: 14850637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of a pro-enzyme by a stoichiometric reaction with another protein. The reaction between prothrombin and staphylocoagulase.
    Hemker HC; Bas BM; Muller AD
    Biochim Biophys Acta; 1975 Jan; 379(1):180-8. PubMed ID: 1115793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in the properties of the coagulase-reacting factor of plasma after separation from prothrombin by Seitz filtration.
    TAGER M; LODGE AL
    J Immunol; 1951 Jul; 67(1):63-9. PubMed ID: 14861417
    [No Abstract]   [Full Text] [Related]  

  • 5. Purification and properties of prothrombin modified by asbestos filtration of human plasma.
    Izuchi Y; Boffa MC; Soulier JP
    Thromb Haemost; 1979 Feb; 40(3):439-53. PubMed ID: 425060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombin III: a backward glance o'er travel'd roads.
    Seegers WH
    Adv Exp Med Biol; 1975; 52():195-215. PubMed ID: 47704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzymatic activities associated with clotting of fibrinogen by staphylocoagulase and coagulase-reacting factor and their inhibition by disopropylfluophosphate.
    DRUMMOND MC; TAGER M
    J Bacteriol; 1962 May; 83(5):975-80. PubMed ID: 13887961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FIBRINOGEN CLOTTING AND FIBRINO-PEPTIDE FORMATION BY STAPHYLOCOAGULASE AND THE COAGULASE-REACTING FACTOR.
    DRUMMOND MC; TAGER M
    J Bacteriol; 1963 Mar; 85(3):628-35. PubMed ID: 14042942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved procedures for the purification of selected vitamin K-dependent proteins.
    Novoa E; Seegers WH; Hassouna HI
    Prep Biochem; 1976; 6(5):307-38. PubMed ID: 787972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new method for purification of staphylocoagulase by a bovine prothrombin-Sepharose column.
    Igarashi H; Morita T; Iwanaga S
    J Biochem; 1979 Nov; 86(5):1615-8. PubMed ID: 521446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of staphylocoagulase in blood coagulation; the reaction of staphylocoagulase with coagulase-globulin to form coagulase-thrombin.
    MIALE JB
    Blood; 1949 Sep; 4(9):1039-48. PubMed ID: 18134769
    [No Abstract]   [Full Text] [Related]  

  • 12. The comparative action of dicumarol and of phenylindanedione on the coagulase reacting factor and on prothrombin.
    TAGER M
    Yale J Biol Med; 1953 Apr; 25(5):374-82. PubMed ID: 13057268
    [No Abstract]   [Full Text] [Related]  

  • 13. Chromatography of blood-clotting factors and serum proteins on columns of diatomaceous earth.
    MILSTONE JH
    J Gen Physiol; 1955 Jul; 38(6):743-55. PubMed ID: 13242761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the coagulase-reacting factor; the reaction of staphylocoagulase with the components of human plasma.
    TAGER M
    Yale J Biol Med; 1948 Mar; 20(4):369-80. PubMed ID: 18907651
    [No Abstract]   [Full Text] [Related]  

  • 15. Toxicity of blood clotting factors.
    MARCINIAK E; RODRIGUEZ-ERDMANN F; SEEGERS WH
    Science; 1962 Aug; 137(3528):421-2. PubMed ID: 14469665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Various molecular states of factor II (prothrombin). Their study by means of staphylocoagulase and anti-factor II antibody. 3. Modifications of factor II (human prothrobmin) in concentrated sodium citrate or ammonium sulfate solution].
    Soulier JP; Hallé L; Prou-Wartelle O
    Thromb Diath Haemorrh; 1968 Nov; 20(1):121-35. PubMed ID: 5708892
    [No Abstract]   [Full Text] [Related]  

  • 17. [Purification of human thrombin by affinity chromatography for its use in preparations for biological coagulation].
    Lorne JL; Allary M; Boschetti E
    Rev Fr Transfus Hemobiol; 1989 Oct; 32(5):391-402. PubMed ID: 2619844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fractionation of plasma globulin for prothrombin, thrombokinase, and accessory thromboplastin.
    MILSTONE JH
    J Gen Physiol; 1951 Sep; 35(1):67-87. PubMed ID: 14873922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Various molecular states of factor II (prothrombin). Their study by means of staphylocoagulase and anti-factor II antibodies. II. Modifications of factor II by passage through asbestos filters].
    Prou-Wartelle O; Soulier JP
    Thromb Diath Haemorrh; 1968 Nov; 20(1):99-120. PubMed ID: 5708901
    [No Abstract]   [Full Text] [Related]  

  • 20. The assay and properties of labile factor (factor V).
    QUICK AJ
    J Clin Pathol; 1960 Nov; 13(6):457-62. PubMed ID: 13738700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.